Inclusion Criteria:
Patients will only be included in the study if they meet all of the following criteria:
  -  Patient who has given informed consent
  -  Patient with age 18 years or older
  -  Patient with locally or distantly advanced breast carcinoma, with at least 1 lesion of at least 12 mm maximal diameter. For lymph node metastases, the largest diameter should be at least 15 mm and the short axis at least 12 mm.
Exclusion Criteria:
Patients will not be included in the study if one or more of the following criteria
applies:
  -  Patient is pregnant
  -  Patient is breast feeding
  -  Patient with recent (< 1 week) gastrointestinal disorders with diarrhea as major symptom
  -  Patient with any serious active infection
  -  Patient who has any other life-threatening illness or organ system dysfunction, which in the opinion of the investigator would either compromise patient safety or interfere with the evaluation of the test radiopharmaceutical
  -  Patient who cannot communicate reliably with the investigator
  -  Patient who is unlikely to cooperate with the requirements of the study
  -  Patient who is unwilling and/or unable to give informed consent
  -  Patient at increased risk of death from a pre-existing concurrent illness
  -  Patient who participated already in this study.